|
【结 构 式】 
|
【分子编号】32556 【品名】N-[2-[([5-[(dimethylamino)methyl]-2-furyl]methyl)sulfanyl]ethyl]-N-[(E)-1-hydrazino-2-nitroethenyl]amine; (E)-N-[2-[([5-[(dimethylamino)methyl]-2-furyl]methyl)sulfanyl]ethyl]-1-hydrazino-2-nitro-1-ethenamine 【CA登记号】 |
【 分 子 式 】C12H21N5O3S 【 分 子 量 】315.39664 【元素组成】C 45.7% H 6.71% N 22.2% O 15.22% S 10.17% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号：(IV)Condensation of primary amine (I) with 1,1-bis(methylthio)-2-nitroethene (II) in refluxing acetonitrile afforded adduct (III). Displacement of the methylthio group of (III) by hydrazine yielded compound (IV), which was finally condensed with glyoxal (V) in the presence of Triton B to produce the target pyridazine.
| 【1】 Chapman, J.M. Jr.; Sowell, W.; Tang, Y.; Kosh, J.W.; Valli, M.J.; Synthesis and cholinergic properties of N-aryl-2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethylamino analogs of ranitidine. J Med Chem 1992, 35, 17, 3141. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 13851 | 2-[([5-[(Dimethylamino)methyl]-2-furyl]methyl)sulfanyl]-1-ethanamine; N-[(5-[[(2-Aminoethyl)sulfanyl]methyl]-2-furyl)methyl]-N,N-dimethylamine | C10H18N2OS | 详情 | 详情 | |
| (II) | 13853 | Methyl 1-(methylsulfanyl)-2-nitrovinyl sulfide; 1,1-Bis(methylthio)-2-nitroethylene; 1,1-Bis(methylsulfanyl)-2-nitroethylene | 13623-94-4 | C4H7NO2S2 | 详情 | 详情 |
| (III) | 32555 | (E)-N-[2-[([5-[(dimethylamino)methyl]-2-furyl]methyl)sulfanyl]ethyl]-1-(methylsulfanyl)-2-nitro-1-ethenamine; N-[2-[([5-[(dimethylamino)methyl]-2-furyl]methyl)sulfanyl]ethyl]-N-[(E)-1-(methylsulfanyl)-2-nitroethenyl]amine | C13H21N3O3S2 | 详情 | 详情 | |
| (IV) | 32556 | N-[2-[([5-[(dimethylamino)methyl]-2-furyl]methyl)sulfanyl]ethyl]-N-[(E)-1-hydrazino-2-nitroethenyl]amine; (E)-N-[2-[([5-[(dimethylamino)methyl]-2-furyl]methyl)sulfanyl]ethyl]-1-hydrazino-2-nitro-1-ethenamine | C12H21N5O3S | 详情 | 详情 | |
| (V) | 32557 | glyoxal; 2-oxoacetaldehyde | 107-22-2 | C2H2O2 | 详情 | 详情 |
Extended Information